Wooyang Balance Sheet Health

Financial Health criteria checks 2/6

Wooyang has a total shareholder equity of ₩41.8B and total debt of ₩68.3B, which brings its debt-to-equity ratio to 163.4%. Its total assets and total liabilities are ₩152.2B and ₩110.4B respectively.

Key information

163.4%

Debt to equity ratio

₩68.29b

Debt

Interest coverage ration/a
Cash₩4.02b
Equity₩41.80b
Total liabilities₩110.39b
Total assets₩152.19b

Recent financial health updates

Recent updates

Investors Give Wooyang Co., Ltd. (KOSDAQ:103840) Shares A 35% Hiding

Jul 12
Investors Give Wooyang Co., Ltd. (KOSDAQ:103840) Shares A 35% Hiding

Investors Aren't Entirely Convinced By Wooyang Co., Ltd.'s (KOSDAQ:103840) Revenues

May 21
Investors Aren't Entirely Convinced By Wooyang Co., Ltd.'s (KOSDAQ:103840) Revenues

Returns On Capital At Wooyang (KOSDAQ:103840) Have Hit The Brakes

Apr 07
Returns On Capital At Wooyang (KOSDAQ:103840) Have Hit The Brakes

Is Wooyang Co. Ltd's (KOSDAQ:103840) 14% ROE Better Than Average?

Mar 11
Is Wooyang Co. Ltd's (KOSDAQ:103840) 14% ROE Better Than Average?

Does Wooyang (KOSDAQ:103840) Have A Healthy Balance Sheet?

Feb 18
Does Wooyang (KOSDAQ:103840) Have A Healthy Balance Sheet?

Are Wooyang's (KOSDAQ:103840) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 31
Are Wooyang's (KOSDAQ:103840) Statutory Earnings A Good Guide To Its Underlying Profitability?

If You Like EPS Growth Then Check Out Wooyang (KOSDAQ:103840) Before It's Too Late

Jan 12
If You Like EPS Growth Then Check Out Wooyang (KOSDAQ:103840) Before It's Too Late

Does Wooyang's (KOSDAQ:103840) Share Price Gain of 53% Match Its Business Performance?

Dec 24
Does Wooyang's (KOSDAQ:103840) Share Price Gain of 53% Match Its Business Performance?

Should We Be Excited About The Trends Of Returns At Wooyang (KOSDAQ:103840)?

Dec 06
Should We Be Excited About The Trends Of Returns At Wooyang (KOSDAQ:103840)?

Can Wooyang Co. Ltd's (KOSDAQ:103840) ROE Continue To Surpass The Industry Average?

Nov 18
Can Wooyang Co. Ltd's (KOSDAQ:103840) ROE Continue To Surpass The Industry Average?

Financial Position Analysis

Short Term Liabilities: A103840's short term assets (₩70.3B) do not cover its short term liabilities (₩93.8B).

Long Term Liabilities: A103840's short term assets (₩70.3B) exceed its long term liabilities (₩16.6B).


Debt to Equity History and Analysis

Debt Level: A103840's net debt to equity ratio (153.8%) is considered high.

Reducing Debt: A103840's debt to equity ratio has reduced from 202.8% to 163.4% over the past 5 years.

Debt Coverage: A103840's debt is not well covered by operating cash flow (14.6%).

Interest Coverage: Insufficient data to determine if A103840's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies